At a glance
- Originator Taiho Pharmaceutical
- Class Anti-ischaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Reperfusion injury
Most Recent Events
- 22 Jan 1998 Preclinical development for Reperfusion injury in Japan (Unknown route)